Overall, our results demonstrated that using a mouse model, the HH3R antagonist clobenpropit could act as a promising neuroprotective target against cognitive impairment, neuronal inflammation, and mitochondrial damage in the brain. Here, HRH3 is linked to Cognitive impairment.